Cardiovascular • May 1-3, 2017
Boston, MA • United States

Paul Underwood, MD

  • Medical Director, Boston Scientific

Paul Underwood, MD, FACC, FSCAI is a native of Knoxville, TN and attended Morehouse College for his premedical studies. He received his MD degree from the Mayo Clinic, followed by a cardiology fellowship at the Cleveland Clinic. His interventional cardiology training was completed at the Iowa Heart Center in Des Moines.

Following his internal medicine training at Mayo, he moved to the Virgin Islands to head the ER and ICU at St. Croix Hospital. After completing his cardiology training, Dr. Underwood practiced interventional cardiology and clinical research in Phoenix for over 18 years. He left clinical practice and joined Boston Scientific in 2009 to become a medical director in the cardiology business.

While in Phoenix he held several hospital committee appointments and was a member of the Arizona Council of the American College of Cardiology. Dr. Underwood has been actively involved in community-based efforts focused on promoting cardiovascular health. He is past president of the Association of Black Cardiologists and founding member for the Center for African American Health-AZ. He served the American Heart Association Desert Mountain Affiliate, as well as, nationally on the Women and Minority Leadership Committee, the Power To End Stroke Advisory Committee and the Science Advisory & Coordinating Committee.

At Boston Scientific, Dr. Underwood recently received the Interventional Cardiology Business Unit Diversity Award for his work with the PLATINUM Diversity trial, the first interventional cardiology study to focus solely on women and minorities. In 2015 he also received the Chairperson’s Award from the National Forum for Heart Disease and Stroke Prevention. He is currently a medical director for the interventional cardiology/structural heart franchise and a member of Close the Gap, Boston Scientific’s health equity education initiative. Dr. Underwood has authored more than 90 peer-reviewed publications and been an investigator in over 90 clinical trials.

This speaker appears at this event: